Soliman, E., Elshahat, A., Mohammed, H., Mohamed, H. (2025). Assessment of the Effect of Vulvovaginal Atrophy on Female Sexual Function Index among Postmenopausal Women Attending Suez Canal University. Suez Canal University Medical Journal, 28(8), 1-8. doi: 10.21608/scumj.2025.445345
Esraa Ayed Mohareb Soliman; Amal Mohammed Elshahat; Heba Saber Mohammed; Hanaa Helmi Mohamed. "Assessment of the Effect of Vulvovaginal Atrophy on Female Sexual Function Index among Postmenopausal Women Attending Suez Canal University". Suez Canal University Medical Journal, 28, 8, 2025, 1-8. doi: 10.21608/scumj.2025.445345
Soliman, E., Elshahat, A., Mohammed, H., Mohamed, H. (2025). 'Assessment of the Effect of Vulvovaginal Atrophy on Female Sexual Function Index among Postmenopausal Women Attending Suez Canal University', Suez Canal University Medical Journal, 28(8), pp. 1-8. doi: 10.21608/scumj.2025.445345
Soliman, E., Elshahat, A., Mohammed, H., Mohamed, H. Assessment of the Effect of Vulvovaginal Atrophy on Female Sexual Function Index among Postmenopausal Women Attending Suez Canal University. Suez Canal University Medical Journal, 2025; 28(8): 1-8. doi: 10.21608/scumj.2025.445345
Assessment of the Effect of Vulvovaginal Atrophy on Female Sexual Function Index among Postmenopausal Women Attending Suez Canal University
Background: Vulvovaginal atrophy is chronic, progressive with age and with hormonal deprivation, which is associated mainly with low estrogens with menopause, but also a slight decline of androgen with age. Vulvovaginal atrophy impacts most before- and after-menopausal women, with rates of prevalence between thirty-six percent and almost ninety percent, as indicated by the latest surveys. Aim: To improve the female sexual function index in postmenopausal women suffering from Vulvovaginal atrophy attending Suez Canal University Hospitals. Subjects and Methods: Postmenopausal women recruited from the outpatient clinic of the obstetrics and gynecology department, Suez Canal university hospital. Patients were subjected to history, examination, to diagnose vulvovaginal atrophy. Vulvovaginal atrophy was screened by interviewing ladies by using vulvovaginal screening questionnaire. This questionnaire includes 14 questions followed by gynecological examination to confirm the vulvovaginal atrophy diagnosis female Sexual Function was assessed through questionnaire. This questionnaire measured the sexual activity through 19 questions divided upon 6 domains: Desire, arousal, lubrication, orgasm, satisfaction, and pain. Results: we found that most of the participants had severe vaginal dryness (41.2%), decreased vaginal lubrication (68.9%) and urinary urgency (89%). On the other hand, the participants who had moderate vaginal discharge were 67.9%, dyspareunia 68%, dysuria was 51.9%, urinary frequency 55.7%, decreased arousal 44.3%, we found that most prevalent vulvovaginal atrophy sign was decreased moisture 94.7%, followed by abnormal discharge 40.3%.we found that participants without severe symptoms had significantly highest arousal score mean±SD (2.63±0.82) and lowest pain score mean±SD (3.95±1.01) than participants with severe symptoms with p value of <0.001 and 0.011, respectively. Conclusion: The female sexual function is less likely to be affected in the presence of moderate to severe VVA symptoms
View on SCiNiTO
Top